Alterity Therapeutics Correlations
ATHE Stock | USD 1.91 0.05 2.55% |
The current 90-days correlation between Alterity Therapeutics and IGM Biosciences is 0.16 (i.e., Average diversification). The correlation of Alterity Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Alterity Therapeutics Correlation With Market
Significant diversification
The correlation between Alterity Therapeutics and NYA is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alterity Therapeutics and NYA in the same portfolio, assuming nothing else is changed.
Alterity |
Moving against Alterity Stock
0.53 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
0.44 | MBFJF | Mitsubishi UFJ Financial | PairCorr |
0.37 | HPQ | HP Inc Fiscal Year End 19th of November 2024 | PairCorr |
0.65 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
0.47 | HD | Home Depot | PairCorr |
0.45 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
0.36 | T | ATT Inc Earnings Call Today | PairCorr |
0.36 | INTC | Intel Aggressive Push | PairCorr |
0.31 | IBM | International Business Financial Report 17th of July 2024 | PairCorr |
Related Correlations Analysis
0.21 | 0.73 | 0.63 | -0.41 | IDYA | ||
0.21 | 0.04 | 0.5 | 0.38 | ANAB | ||
0.73 | 0.04 | 0.63 | -0.34 | TNYA | ||
0.63 | 0.5 | 0.63 | 0.01 | IGMS | ||
-0.41 | 0.38 | -0.34 | 0.01 | MRUS | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Alterity Stock performing well and Alterity Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alterity Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IDYA | 2.06 | (0.26) | 0.00 | (0.12) | 0.00 | 2.74 | 10.88 | |||
ANAB | 3.27 | 0.03 | 0.01 | 0.04 | 4.43 | 11.29 | 25.02 | |||
TNYA | 3.23 | (0.73) | 0.00 | (0.30) | 0.00 | 5.74 | 18.46 | |||
IGMS | 4.68 | (0.41) | 0.00 | (0.58) | 0.00 | 9.57 | 48.77 | |||
MRUS | 2.70 | 0.42 | 0.15 | 0.46 | 2.51 | 6.11 | 44.66 |
Alterity Therapeutics Corporate Management
Robert Cherny | Head Research | Profile | |
BBus CA | Company Sec | Profile | |
BSc BSc | CoFounder Chairman | Profile | |
Kathryn Andrews | Chief Officer | Profile | |
Steven Targum | Chief Advisor | Profile | |
CPA BCom | Chief Officer | Profile |